Research Overview: Nolvadex 10mg Shield Pharma
Nolvadex 10mg Shield Pharma is a selective estrogen receptor modulator (SERM) formulated for comprehensive laboratory research applications. This pharmaceutical-grade compound enables researchers to investigate the complex mechanisms of estrogen receptor modulation and hormonal pathway interactions in controlled experimental environments. The 10mg concentration provides precise dosing capabilities for detailed molecular studies, making it an essential compound for institutions examining endocrine system function and receptor binding dynamics.
Research scientists at Stroid UK Shop utilise this compound to study estrogen receptor antagonism and agonism across various tissue types. The Shield Pharma formulation ensures consistent molecular composition, enabling reproducible results across multiple experimental protocols. Researchers investigating comparative studies between different estrogen modulation compounds frequently select this preparation for its reliable pharmaceutical standards and documented molecular stability.
Laboratory Research Applications
This SERM compound facilitates extensive research into estrogen receptor binding affinity and tissue-selective modulation mechanisms. Laboratory studies examine how selective receptor modulation influences cellular signalling pathways, gene expression patterns, and protein synthesis regulation. Research applications include investigating receptor antagonism in breast tissue models while simultaneously studying potential agonistic effects in bone tissue samples.
Advanced molecular biology research programmes utilise this compound to study post-cycle therapy mechanisms and hormonal axis recovery patterns in experimental models. Comparative studies with selective androgen receptor modulators provide valuable insights into receptor selectivity and tissue-specific responses. Research protocols examining the interaction between estrogen modulation and peptide hormone systems utilise this compound for comprehensive endocrine research applications.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Tamoxifen Citrate |
| Concentration | 10mg per unit |
| Manufacturer | Shield Pharma |
| Molecular Formula | C26H28ClNO·C6H8O7 |
| Molecular Weight | 563.62 g/mol |
| CAS Number | 54965-24-1 |
| Storage | Room temperature, dry conditions |
| Research Use | In-vitro laboratory studies only |
Research Compliance
This product is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must ensure appropriate institutional oversight and safety protocols when handling this compound.
